Traumatic Ulcer of Oral Mucosa
Conditions
Keywords
traumatic oral ulcer- low level laser therapy- chlorohexidine- lidocaine
Brief summary
the goal of the study was to evaluate the pain reduction and healing efficiency of traumatic oral ulcers in children using low-level laser therapy with diode laser 980 nm, lidocaine oral gel and chlorhexidine mouthwash
Detailed description
thirty children were randomly allocated to three groups of ten individuals each: Group one: therapy, Group two: using Lidocaine gel 4 times daily and Group three using chlorhexidine mouthwash 4 times daily . Assessment was done by evaluating pain by Visual Analogue scale; VAS (primary outcome) and assessment of ulcer size by periodontal probe (Secondary outcome) and Parental acceptance of the therapy (tertiary outcome) immediately after treatment, at day two, five, seven, then at two weeks
Interventions
RADIATIONlow level laser therapy group
patients received low level laser therapy using diode laser 980 nm with a low power
patients was instructed to use Lidocaine gel (Oracure gel) 4 times daily.
DRUGChlorhexidine mouthwash group (positive control group).
patients was instructed to use Chlorhexidine mouthwash (Orovex) 4 times daily (control group).
Sponsors
National Research Centre, Egypt
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
the outcomes assessor was un aware of the type of treatment given to the patient
Intervention model description
the study design was a single blinded randomized clinical study
Eligibility
Sex/Gender
ALL
Age
4 Years to 12 Years
Healthy volunteers
No
Inclusion criteria
* Children from 4-12 years without any apparent medical problem * Children with history of receiving a dental procedure in the same or the previous day of the onset of ulcer. * Children having restorations or teeth with sharp edges. * Children with orthodontic or any other oral appliance. * No previous treatment with any modality for the ulcer. * Willingness to participate in the proposed clinical study.
Exclusion criteria
* Patients who had psychological or mental diseases. * Patient under anticoagulants, anti-inflammatory or immunosuppressant medications. * Children with systemic (endocrine-metabolic) disease; rheumatologic disease; hormone disorder; immunodeficiency; use of corticoid-based therapy. * Uncooperative children or parents. * Patients who did not participate twice weekly in the evaluations were excluded
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Subjective pain assessment of the ulcer | 2 weeks | evaluation of pain associated with the ulcer will be evaluated using visual analoque scale (VAS) before the onset of treatment then follow up of the degree of pain relief associated with treatment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Objective assessment of the ulcer size | 2 weeks | evaluation of the ulcer size will be done using a graded periodontal probe before the onset of treatment then follow up of the degree of decrease in ulcer size (indicating healing) associated with treatment |
| Parental satisfaction | 2 weeks | Parental satisfaction towards treatment procedures, related to duration and frequency of treatment visits will be evaluated using a questionnaire that will be received and answered by the parents at the end of treatment |
Countries
Egypt
Outcome results
None listed